Gilead Sciences (GILD) Minority Interest (2009 - 2026)

Gilead Sciences (GILD) has reported Minority Interest for 18 consecutive years, with -$84.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Minority Interest changed 0.0% year-over-year to -$84.0 million; the trailing twelve-month figure through Jun 2026 stood at -$84.0 million (changed 0.0% YoY), and the FY2025 full-year result was -$84.0 million, changed 0.0% from the prior year.
• Minority Interest was little changed at -$84.0 million in Q2 2026 per GILD's latest filing, from -$84.0 million in the prior quarter.
• Across five years, Minority Interest topped out at -$12.0 million in Q1 2022 and bottomed at -$84.0 million in Q4 2023.
• Historically, Minority Interest has averaged -$67.0 million across 5 years, with a median of -$84.0 million in 2023.
• The sharpest annual moves came in 2022 and 2024: Minority Interest sank 2500.0% in 2022, then changed 0.0% in 2024.
• Over 5 years, Minority Interest stood at -$31.0 million in 2022, then sank by 170.97% to -$84.0 million in 2023, then changed by 0.0% to -$84.0 million in 2024, then changed by 0.0% to -$84.0 million in 2025, then changed by 0.0% to -$84.0 million in 2026.
• According to Business Quant data, Minority Interest over the past three periods registered -$84.0 million, -$84.0 million, and -$84.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.